Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0350
+0.0134 (62.04%)
Nov 12, 2026, 1:57 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 7.71 million as of November 11, 2026. It is the 44,186th most valuable company in the world and the 203rd biggest in Switzerland. Its market cap has increased by 12.21% in one year.
Market Cap
7.71M
Enterprise Value
7.02M
Revenue
83.07K
Global Rank
Country Rank
#203 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 7.71M, a decrease of -98.06%. That is a compound annual growth rate of -18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 7.71M | 19.45% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.04B |
| Idorsia | 1.13B |
| Basilea Pharmaceutica AG | 903.38M |
| Santhera Pharmaceuticals Holding AG | 232.06M |
| Newron Pharmaceuticals | 195.19M |
| BioVersys AG | 131.97M |
| Molecular Partners AG | 94.31M |
| Xlife Sciences AG | 49.60M |